MDMA is a national trade association that provides educational and advocacy services to medical technology innovators. For over 25 years, MDMA has served as the eyes and ears for the medical device industry in Washington, DC and beyond. We provide advocacy services on behalf of the industry that promote patient access and innovation. We offer professional development services to member company personnel including conferences and a variety of other educational resources. Our mission is to ensure patients have timely access to safe and effective medical products that improve health outcomes.

Advisory services for healthcare companies, industry associations and other organizations that want to effectively engage with policymakers or simply develop a better understanding of how government legislation and regulations impact their operations. Available for speaking engagements and advisory/fiduciary board roles.

Opus Faveo is dedicated to building companies, supporting innovation, researching important issues and advising large organizations on innovation policy. Projects included working to expand the firm's innovation strategy consulting practice and developing a media relations plan to support the launch of a new "University Innovation Impact Index" developed in collaboration with the George W. Bush Institute.

Responsible for the company’s corporate communications, media relations, government relations, community affairs and charitable functions and programs. Led an organization consisting of more than 35 professionals across three functional departments with an annual budget ranging from $9M to $12M. Reported directly to the CEO and served on the company’s Executive Leadership Team.Designed and executed communications plans for significant strategic transactions, including the $4.2 billion joint venture with United Surgical Partners International and the $4.3 billion acquisition of Vanguard Health Systems, Inc., as well as numerous hospital acquisitions and divestitures, crisis situations, and financial and corporate governance announcements. Responded to the expansion of Medicaid and private insurance coverage under the Affordable Care Act (ACA) by developing and implementing a centrally supported, locally tailored program to engage and educate communities served by Tenet hospitals about new coverage options, resulting in more than 350,000 enrollments during the 2013 and 2014 ACA open enrollment periods.Regularly advised the company’s board of directors on matters related to corporate political engagement, legislation and government policy trends, and compliance with lobbying and campaign finance law.

Provided strategic leadership for the company’s government advocacy programs and external industry relationships at the federal and state level. Established a company office in Washington, DC and served as the company’s principal federal lobbyist and a key advisor on federal legislation and regulatory policy. Led a geographically dispersed team of three to five directors plus support staff and external consultants. Organized and oversaw all company advocacy activities supporting the enactment of the Affordable Care Act (ACA), including direct lobbying and grassroots advocacy.Restructured the department staff, eliminated or consolidated consultant contracts, and made programmatic changes to achieve annual budget savings of more than 25%.

Developed and executed lobbying and advocacy strategies to secure and increase federal reimbursement for the company’s medical device products. Worked collaboratively with subject matter experts and operational leaders to develop company policy positions, and managed a range of outside consultants and contract lobbyists. Served as a key adviser to the Vice President of Federal Affairs on department organization and administration.Served as a federally appointed member of the Medicare Competitive Bidding Program Advisory and Oversight Committee, advising the Centers for Medicare and Medicaid Services on the design of a new durable medical equipment reimbursement system (2004–2005).

Advised medical technology companies, including St. Jude Medical and Johnson & Johnson, on federal healthcare policy issues and represented clients before Congress, the Administration, the U.S. Food and Drug Administration and the Centers for Medicare and Medicaid Services.

Managed the daily activities of a lobbying and healthcare policy consulting firm led by former U.S. Senator David Durenberger (R-MN). Advised and represented medical device companies and other healthcare organizations before Congress and federal agencies. Responsible for meeting planning and other administrative operations of the Medical Technology Leadership Forum, a consortium of medical device companies, academic medical centers, medical specialty societies and patient advocates.

Served as external regulatory policy counsel to the Medical Device Manufacturers Association, a national association representing entrepreneurial-stage medical technology companies.Assembled, annotated and edited a comprehensive legislative history of the Food and Drug Administration Modernization Act of 1997 published by the Food and Drug Law Institute (1998).

Tracked, analyzed and coordinated advocacy on significant federal legislation, including the Food and Drug Administration Modernization Act of 1997, the Balanced Budget Act of 1997, and the Biomaterials Access Assurance Act of 1998. Represented the company in national and regional industry associations such as AdvaMed, Medical Alley, the California Healthcare Institute and MassMEDIC.